Hi ,

I'll be speaking at Nucleate Taiwan on Tuesday, June 25th! Join us for a thrilling journey into the vast array of career and professional opportunities within the rapidly growing synthetic biology (SynBio) space! Register now.

This week’s digest is brought to you by Insempra, a biotechnology-powered company enabling businesses to transform their ingredient lists with superior products made in collaboration with nature. Insempra’s advanced technology platform enables the production of superior natural ingredients on an industrial scale to help the world’s leading brands transform their products. Check out the Insights piece about Insempra below.

Our SynBioBeta 2025 Early Bird Pricing is still available. Register today to take advantage of our lowest rates. 

This week, former SynBioBeta editor Kevin Costa and CMO/brand builder Jack Gold teamed up to launch Beakers & Chips, a brand marketing studio on a mission to help science and tech startups build powerful brands and compelling narratives without the overhead of a full marketing team. They will draw on their experiences taking Zymergen to a $580mm IPO and transforming Absci into a pharma market leader to help innovators achieve their true market potential.

Cibele Zolnier, Executive Director at SynBioBR, penned a wonderful piece about her time at SynBioBeta2024 and connecting with other members of the worldwide synthetic biology community. We’re so glad Cibele and her colleagues could all make the trip and contribute to advancing this amazing field! Read her article here .

Cibele Zolnier with many of her colleagues at SynBioBeta 2024.

Insights (Exclusive Content):

• Series A? More Like Series Amazing: Insempra’s $20M Win. Growing fast, with a laser focus to market, Insempra might become the success story the synbio community needs right now.
  

• The Ethics Of Accessibility: Who Controls The Power In Synthetic Biology? Balancing the benefits and risks of synthetic biology involves complex decisions about regulation, societal impact, and responsible use of technology.

Industry News:

• IDT Unveils State-of-the-Art Synthetic Biology Hub, Propelling Innovation in Coralville, Iowa. This expansion marks a significant augmentation of its synthetic biology operations, doubling its footprint in this critical field.

• Allonnia Teams Up with Terra Systems to Tackle Groundwater Contamination Across North America: In a bid to tackle groundwater contamination, Allonnia, the pioneering bio-ingenuity firm, has inked a pivotal distribution agreement with Terra Systems, heralding a new era in environmental remediation efforts.

• Enveda Biosciences ("Enveda"), a pioneering biotechnology firm harnessing AI to unlock nature's pharmaceutical potential, made waves with the announcement of a groundbreaking collaboration with tech titan Microsoft.

• HuidaGene and Synthego Forge Partnership to Advance CRISPR-Based Therapies: hfCas12Max, born from HuidaGene's HG-PRECISE platform, emerges as a standout CRISPR gene-editing system, distinguished by its unparalleled on-target editing efficiency and minimized off-target editing activity in mammalian cells.

Interested in being part of the 2025 conference as a sponsor or exhibitor? Contact Anissa Cooke to learn about available opportunities and check out our 2025 prospectus.

Additional Industry News:

• The International Biosecurity and Biosafety Initiative for Science (IBBIS) announced the launch of the Common Mechanism, an open-source, globally available tool for DNA synthesis screening. Tessa Alexanian made the announcement on the main stage of SynBioBeta.

• Introducing BIO: Your Gateway Drug to DeSci: BIO is coming – a new protocol for routing resources to the best scientific IP onchain. The protocol’s native governance token, BIO, has been airdropped to thousands of DeSci’s early adopters ahead of the network’s upcoming “ABIOGenesis” bootstrapping phase.

• Sphere Fluidics Launches Cyto-CellectPLUS to Accelerate Cell Line Development Workflows. Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells (Press release)

• Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety: Twist joins leading AI stakeholders to help advance the development and deployment of safe, trustworthy AI under the new U.S. Government safety institute (Press release)

• Modern Meadow Announces Sale of its Beauty and Biomedical Applications and Appoints New President/Chief Operating Officer and Executive Chair (Press release)

• US lawmakers ask FBI for briefing on GenScript Biotech's links to China: The U.S. House of Representatives committee on China has asked the FBI and the intelligence community for a briefing on GenScript Biotechnology Co and three subsidiaries to determine if the Chinese Communist Party has influence over their operations. (Reuters)

Who's hiring?

• Group Leader, Metabolism at NewLimit (South San Francisco, CA)
  

• Head of Operations at NewLimit (South San Francisco, CA)